baber/WOPTO huggingface dataset:
Patent DK-212587-A (DK)
Inventor: SCHULTZ RICHARD H
IPC: A61K/
Filed: 1987-04-27
Abstract: The present disclosure is concerned with the discovery that hyaluronic acid, an agent well known to reduce the sequelae of trauma in mammalian joint tissue when applied directly to the traumatized tissue, will be carried to such traumatized tissue by the mammal's natural processes if applied at a site remote from the traumatized tissue. Thus, hyaluronic acid, in any therapeutically acceptable form, can be administered by the typical remote routes including intravenous, intramuscular, subcutaneous and topical. This makes the utilization of hyaluronic acid much more convenient and attractive. For instance the treatment of arthritis in horse or human joints with hyaluronic acid no longer requires more difficult intra articular injections.
Patent DK-231682-A (DK)
Inventor: JACKSON G
IPC: C07H5/02
Filed: 1982-05-21
Abstract: Compounds of the general formula (I) are potent sweeteners, especially 4,1',6'-tribromo-4,1',6'-trideoxygalactosucrose:   <IMAGE> (I)  in which R' represents a chlorine or bromine atom; R2 and R3 respectively represent a hydroxy group and a hydrogen atom or a hydrogen atom and a chlorine or bromine atom; R4 represents a chlorine or bromine atom; at least one of R', R3 and R4 representing a bromine atom.
Patent DK-273189-A (DK)
Inventor: LAWRENCE GORDON C
IPC: A01N43/90
Filed: 1989-06-02
Abstract: Compounds of formula (1) <CHEM>  and their salts, wherein R<1> is a methyl, ethyl or isopropyl group each substituted by a hydroxyl group or R<1> is a group -(CH2nR7 or a group -CH(CH3)R<7> (where n is zero or 1 and R<7> is CHO or CO2H); Y<1> is -CH2-, Y<2> is -CH- and X represents <CHEM> [where R<2> is a hydrogen atom or a group OR<8> is a hydroxyl group or a substituted hydroxyl group having up to 25 carbon atoms) and R<3> is a hydrogen atom, or R<2> and R<3> together with the carbon atom to which they are attached represent >C=O, >C=CH2 or >C=NOR<9> (where R<9> is a hydrogen atom or a C1-8 alkyl or C3-8 alkenyl group) and the group >C=NOR<9> is in the E configuration] or -Y<1>-X-Y<2>- represents -CH=CH-CH- or -CH2-CH=C-; R<4> is a group OR<8> as defined above and R<5> is a hydrogen atom, or R<4> and R<5> together with the carbon atom to which they are attached represent >C=O or >C=NOR<9><a> (where R<9><a> is as defined above for R<9>); and  R<6> is a hydrogen atom or a hydroxyl group. The compounds may be used to control nematode, acarine, insect or other pests.
Patent DK-284085-A (DK)
Inventor: GASC JEAN-CLAUDE
IPC: C07D498/04
Filed: 1985-06-24
Abstract: 1. Derivatives of isoxazoloquinolinone characterized in that they answer to the general formula l  see diagramm : EP0168309,P8,F1  in which R represents a hydrogen, fluorine, chlorine or bromine atom, a linear alkyl radical containing from 1 to 5 carbon atoms, or branched alkyl radical containing from 3 to 5 carbon atoms, an alkoxy radical containing from 1 to 5 carbon atoms, a nitro or trifluoromethyl radical and R1  represents a phenyl radical possibly substituted by a linear alkyl radical containing from 1 to 5 carbon atoms, or a branched alkyl radical containing from 3 to 5 carbon atoms, by an alkoxy radical containing from 1 to 5 carbon atoms, or by a halogen atom.
Patent DK-321184-A (DK)
Inventor: FUERST KARL
IPC: A47K3/00
Filed: 1984-06-29
Abstract: A seat bath unit for elderly, frail or otherwise handicapped persons is provided wherein a sidewall of the bathtub is displaceable for complete opening to the seat part for access thereto. A catchment trough beneath the bathtub is provided for receiving the total amount of water from the bathtub when bathing is complete so that the bathtub can be quickly emptied.
Patent DK-372881-A (DK)
Inventor: BAXTER J D
IPC: C12N15/62
Filed: 1981-08-24
Abstract: A DNA transfer vector comprises a deoxynucleotide sequence coding for bovine growth hormone or bovine pre-growth hormone.
Patent DK-408985-A (DK)
Inventor: OTT HANS
IPC: H05B39/08
Filed: 1985-09-09
Abstract: 1. Switching arrangement having a first connecting terminal (1) for an outer conductor of the supply system and a second connecting terminal (2) for a connecting conductor leading to the load, wherein the two connecting terminals (1 and 2) are bridged by an electrical switch (3) which is triggered by electronic elements (4, 5) which are connected to converter arrangements, characterised in that - the electrical switch (3) is triggered by an output stage element (4), of which the first terminal connecting member (43) is connected to the two connecting terminals (1, 2) by way of a first converter arrangement which rectifies the negative half-cycle of the supply voltage, - the output stage element (4) is connected to a control element (5), of which the first terminal connecting member (53) is connected to the two connecting terminals (1, 2) by way of a second converter arrangement which rectifies the positive half-cycle of the supply voltage, and - the second terminal connecting members (44 and 54) of the output stage element (4) and of the control element (5) are directly connected to the first connecting terminal (1) of the outer conductor as reference potential.
Patent DK-443587-A (DK)
Inventor: WALSGROVE TIMOTHY CHARLES
IPC: C07D209/34
Filed: 1987-08-25
Abstract: A process for the preparation of a compound of structure (I) <CHEM> in which, each group R is hydrogen, C1-6alkyl, C3-6allyl, phenylC1-6alkyl or 4-hydroxyphenylC1-6alkyl; R<1>, R<2> and R<3> are hydrogen or C1-6alkyl; R<4> is hydrogen or hydroxy: and n is 1 to 3 or a pharmaceutically acceptable salt thereof, which comprises reduction of a compound of structure (II) <CHEM> in which R, R<2> to R<4> and n are as described above and R<5> is hydrogen or a cation, followed by cyclisation of the intermediate so formed, and, optionally, alkylating to form a compound of structure (I) in which R<1> is C1-6alkyl and, optionally, forming a pharmaceutically acceptable salt thereof, characterised in that the reduction of the compound of structure (II) is carried out by catalytic transfer hydrogenation in water as a solvent.
Patent DK-455180-A (DK)
Inventor: PORTNER P M
IPC: A61M5/00
Filed: 1980-10-28
Abstract: Multiple embodiments of an implantable infusion device for delivering precisely regulated dosages of drugs are disclosed, each device including reservoir means for containing the drug, catheter means for delivering the drug to the body and an actuating means which is responsive to a signal applied externally of the body for initiating delivery of a precisely regulated dosage. In one embodiment, the device is implanted subcutaneously to permit actuation by a solenoid driven element responsive to coded telemetry signal applied through the skin. In additional embodiments, the reservoir is pressurized for example, by means of vapor pressure or a mechanical spring, the drug under pressure in the reservoir being released in response to an externally applied signal.
Patent DK-510282-A (DK)
Inventor: BRAESTRUP CLAUS THYCO
IPC: C07D487/04
Filed: 1982-11-16
Abstract: New oxadiazolyl-imidazo-[1,4]benzodiazepine derivatives having benzodiazepine receptor activity have the formula  <IMAGE>  R' is hydrogen, chlorine, fluorine or nitro in the 7- or 8-position, R1 is hydrogen or lower alkyl of up to 3 carbon atoms, R3 is the oxadiazolyl grouping of the formula  <IMAGE>  wherein R'' is lower alkyl with up to 3 carbon atoms and A   B is a grouping of the formula  <IMAGE>   wherein R5 is hydrogen or methyl and R''' is hydrogen or chlorine. The compounds possess valuable pharmacological properties. In particular, they act on the central nervous system and are suitable for use in psychopharmaceutical preparations.
Patent DK-517789-A (DK)
Inventor: SIMON HERBERT
IPC: C07D211/58
Filed: 1989-10-18
Abstract: The present invention provides anti-angina pharmaceutical compositions containing at least one compound of the formula:  (* CHEMICAL STRUCTURE *) (I) wherein n is 1 or 2, R is a hydrogen atom or an H-(C1-C8)-alkylene, hydroxy-(C1-C8)-alkylene, R1R2N-(C1-C8)-alkylene, R1R2N-(C1-C8)-alkylene-CO-, R1R2N-CO-NR3-(C1-C8)-alkylene or R1R2N-CO- radical, A is a valency bond or an -NR4-CO- or -CO- NR4- radical, R4 is a hydrogen atom or a straight-chained or branched, saturated or unsaturated or cyclic alkyl radical containing up to 6 carbon atoms and B is a valency bond or a straight-chained or branched alkylene chain containing up to 8 carbon atoms, in which a -CH2- group can be replaced by a cycloalkylene radical containing 3 to 7 carbon atoms.
Patent FI-833074-A (FI)
Inventor: HARDIE JANET
IPC: C07D231/40
Filed: 1983-08-30
Abstract: This invention relates to three polymorphic forms of 5-[3-(2-[2,2,2-trifluoroethyl]guanidino)-pyrazol-1-y] valeramide, two of which are practically crystallographically pure, and to processes for their manufacture.
Patent FI-865257-A (FI)
Inventor: HEERES JAN
IPC: A61K31/495
Filed: 1986-12-22
Abstract: Novel lH-imidazoles and lH-l,2,4-triazoles of formula <CHEM>  wherein Y-R<1> is a radical having the formula <CHEM> the pharmaceutically acceptable acid addition salts and possible stereochemically isomeric forms thereof, which compounds are antimicrobial agents; pharmaceutical compositions containing such compounds as an active ingredient and methods of preparing said compounds and pharmaceutical compositions.
Patent FI-874880-A (FI)
Inventor: HERFORT HERMANN
IPC: H01R4/24
Filed: 1987-11-04
Abstract: A cutting/clamping terminal element for electrical conductors (14) is disclosed including a clamping slot (0) defined between a clamping piece (4) and an elastic clamping leg (2,3; 23, 13) to ensure an improved contact connection, such that even conductors (14) having very thin conductor core diameters, in particular wire strands, can be connected, without the conductor cross section being reduced and without there being a risk of conductor breakage. For this purpose, the clamping piece (4) is provided with clamping legs (2,3; 12,13) arranged on its front and rear sides, said clamping legs overlapping in the position of rest the clamping piece (4) at least in part, such that the sharp edges (15,24) of the two clamping legs (2,3; 12,13) and of the clamping piece (4) cut into the insulation (11) and clamp the core (10) of the conductor (14) in the clamping slot (9) at in total three different positions.
Patent FI-880629-A (FI)
Inventor: REYNOLDS ERIC CHARLES
IPC: A23L29/00
Filed: 1988-02-11
Abstract: ep87305hopeptide or a salt thereof the phosphopeptide having from 5 to 30 amino acids including the sequence A-B-C-D-E where A, B, C, D and E are independently phosphoserine, phosphothreonine, phosphotyrosine, phosphohistidine, glutamate and aspartate and compositions particularly compositions to teeth including same.
Patent FI-881417-A (FI)
Inventor: BENDER ARNE
IPC: A01F29/02
Filed: 1988-03-24
Abstract: A device for chopping straw of the type which comprises a rotor arranged in an apparatus housing, said rotor having a plurality of knife arms detachably attached thereto and which when rotated pass between a number of counter-knives attached to a knife beam. The knife arms and counter-knives comprises flat bars provided with at least one sharpened edge on one of its long sides. The knife arms are arranged to act as fan blades guiding the air stream with chopped straw exiting from the apparatus housing, by the fact that each knife arm has said at least one edge bevelled in a respective oblique sharpening plane extending substantially throughout the thickness of respective knife arm. A desired spreading direction and spreading width of the chopped straw is obtained by arranging the detachable knife arms with their sharpening planes in different configurations with respect to each other.
Patent FI-884070-A (FI)
Inventor: ARROWSMITH JOHN EDMUND
IPC: A61K/
Filed: 1988-09-02
Abstract: The invention provides sulphonamide antiarrythmic agents of the formula: <CHEM> wherein each R, which is the same, is a C1-C4 alkyl group; X is CH2 or O; and Y is O or a direct link; or a pharmaceutically acceptable salt thereof.
Patent FI-910368-A (FI)
Inventor: HSU OSCAR HSIEN-HSIANG
IPC: B27N3/08
Filed: 1991-01-24
Abstract: A prepress sealer composition, which incorporates a crosslinking resin and an aqueous dispersion of acrylic polymer particles, the acrylic polymer particles having a THF gel content of greater than about 70%, is used to improve press release during board manufacture and improved surface toughness and water resistance to the board so produced.
Patent FI-910423-A (FI)
Inventor: WARIS JUHANI
IPC: A41D5/00
Filed: 1991-01-29
Abstract: The invention relates to a method for connecting a fur strip to a base material and a guiding device therefor. The invention is based on that fur strip is achieved to go through the gap (1) the needles (2) being on both sides thereof and to keep the strip skin essentially parallel with the base material in gap (1), so that the hairs are in an upright position and that strip can be connected to the base material by means of a sewing machine with two needles and three or four threads. The hairs of the strip come to the fan type form after sewing. <IMAGE>
Patent FI-915523-A (FI)
Inventor: BURGER RAYMOND
IPC: B30B5/06
Filed: 1991-11-25
Abstract: Device characterised in that, at each lateral edge of the band (1) is arranged a handling chain (2), each of the metal plates (1') being connected to at least one of the links (2') of each handling chain (2), and in that the pinions (13) engaging with the rolling chain or chains (4) are arranged, at each end of the device, between the pinions (11) engaging with the handling chains (2) and over the same shaft (8) as the latter, the drive ratio between the two types of pinions (11, 13) being such that the linear speed of the endless metal band (1) is equal to twice the linear speed of the rolling chains (4). 
<IMAGE>
Patent FI-921091-A (FI)
Inventor: SHAW KENNETH
IPC: C07D/
Filed: 1992-03-13
Abstract: The invention relates to a process for preparing an imidazo[1,5-a]quinoxaline-1,3-dione derivative of the formula I, <IMAGE> in which R1 and R4 denote hydrogen, alkyl or alkoxy, X is hydrogen, halogen, hydroxyl, amino or mono- or dialkylamino, W is an optionally substituted phenyl, thienyl or pyridyl group, and R2 and R3 denote hydrogen or various substituents as defined in the patent claims, and their pharmaceutically acceptable salts. These compounds are extremely selective brain GABAa receptor agonists, antagonists or invert agonists or their precursors and they can be used for diagnosing and treating anxiety, sleep disturbances and disease attacks, overdosing with drugs of the benzodiazepine type and for improving the memory.
Patent FI-921346-A (FI)
Inventor: BOOHER RICHARD NOLAN
IPC: A61P25/22
Filed: 1992-03-27
Abstract: 6-Heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz-[cd]indoles are provided which are useful in modifying the function of serotonin in mammals.
Patent FI-921875-A (FI)
Inventor: HRIB NICHOLAS J
IPC: C07D261/20
Filed: 1992-04-27
Abstract: The present invention relates to benzisothiazole- and benzisoxazole-3-carboxamides of the formula I <CHEM> wherein R<1> is hydrogen or loweralkyl; R<2> is loweralkyl, or a group of the formula <CHEM> R<3> is hydrogen or loweralkyl; A is loweralkylene, a group of the formula -CHR<4>CH=CHCHR<4>-, or -CHR<4>C IDENTICAL CHR<4>-; R<4> is hydrogen or loweralkyl; X is O or S; W is N or CH; Y is hydrogen, loweralkyl, loweralkoxy, hydroxy, halogen, or trifluoromethyl; Z is hydrogen, loweralkyl, loweralkoxy, hydroxy, halogen, or trifluoromethyl; n is 1 or 2; wherein the solid line (-) refers to the point of attachment of the group to the indicated member of the formula; the geometric and optical isomers thereof; or a pharmaceutically acceptable salt thereof, useful for the treatment of psychoses, alone or in combination with inert adjuvants.
Patent FI-922589-A (FI)
Inventor: BOIGEGRAIN ROBERT
IPC: A61P1/04
Filed: 1992-06-04
Abstract: These compounds correspond to the formula: 
<IMAGE>
 in which R1 represents H or an alkyl, phenylalkyl, aminoalkyl, optionally esterified carboxyalkyl, cyanoalkyl, carbamoylalkyl, hydroxyalkyl or alkoxyalkyl group; RIV represents an optionally substituted cycloalkyl group or an aromatic group such as an optionally substituted phenyl or heterocycle or RIV and RV together represent the group: 
<IMAGE>
 in which u has the value 1 to 3, optionally carrying (np) substituents Xp chosen from halogen, alkyl, alkoxy, nitro and trifluoromethyl, and np have a value from 0 to 3; RV represents a group (CH2)m-X in which m is 0 to 5 and X represents a halogen, a cycloalkyl, an optionally substituted phenyl, a group COOX1; -O-COX1; -SCOX1; (O)q-S-X1 with q = 0, 1 or 2; -O-COOX1; -N-X3-CO-X1 with X3 = H or alkyl; 
<IMAGE>
 with W = O or S and X1 being a C1 to C3 alkyl or an optionally substituted phenyl; a group -COX1X2; -O-CO-NX1X2; or -NX1X2; in which X1 represents an alkyl or phenyl which can be substituted, an alkoxy, or an optionally substituted cyclic or linear amine; a hydroxyl or carboxylic acid group; and Z represents a heterocycle containing one or more heteroatoms chosen from O, S and N, condensed with an aromatic ring which can also contain a heteroatom and which can be substituted, as well as their addition salts.
Patent FI-923056-A (FI)
Inventor: HANSEN AOKE
IPC: G05D1/08
Filed: 1992-07-01
Abstract: The invention relates to an arrangement for determining the roll angle attitude of a rotating projectile, grenade, missile or the like (1) with the aid of polarised electromagnetic radiation, comprising a transmitter (2) arranged to emit a position-determining polarised radiation space wave (4) in the direction of the projectile and a receiver (5) arranged in the projectile for receiving the emitted radiation. The emitted space wave is made up of a carrier wave reference with frequency f1 which is phase-modulated with a modulation frequency f2, where f2 < = f1 and forms a submultiple of the carrier wave frequency f1. <IMAGE>
Patent FI-924343-A (FI)
Inventor: LEW PATRICK J
IPC: A61N1/30
Filed: 1992-09-28
Abstract: An iontophoretic agent delivery device having donor and counter electrodes comprised of either metal or a hydrophobic polymer loaded with a conductive filler is provided. The agent reservoir in the donor electrode assembly contains about 10 to 60 wt. % hydrophobic polymer, about 10 to 60 wt. % hydrophilic polymer, and up to 50% agent. Similarly, the electrolyte reservoir contains about 10 to 60 wt. % hydrophobic polymer, about 10 to 60 wt. % hydrophilic polymer, and up to 50% electrolyte. The agent reservoir, the electrolyte reservoir and the electrodes are preferably in the form of films which are laminated to one another. The hydrophobic polymer component in the agent/electrolyte reservoir prevents the reservoir from delaminating from the metal/hydrophobic polymer based electrode, even after hydration of the reservoirs.
Patent FI-954855-A (FI)
Inventor: BERTINA ROGIER MARIA
IPC: C12Q1/6883
Filed: 1995-10-12
Abstract: Method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein C (APC). The method is directed at detecting one or more mutations at one or more of the cleavage and/or binding sites for APC of Factor V and/or Factor Va or at Factor VIII and/or Factor VIIIa at either nucleic acid or protein level or both.
Patent FI-961080-A (FI)
Inventor: MAIER REINHARD
IPC: H02H3/00
Filed: 1996-03-07
Abstract: PCT No. PCT/DE93/00825 Sec. 371 Date Mar. 8, 1996 Sec. 102(e) Date Mar. 8, 1996 PCT Filed Sep. 8, 1993 PCT Pub. No. WO95/07571 PCT Pub. Date Mar. 16, 1995An AC power controller includes at least two semiconductor regions reverse-connected in series. Each semiconductor region has an electron donor (source), an electron sink (drain) and an electron flow control electrode (gate) with characteristic curves such as those exhibited by FETs. Each semiconductor region also has an internal body diode. The gate-source voltage of a respective semiconductor region in the forward direction is set to be large enough to establish a desired limiting of the drain-source current. Yet, the gate-source voltage of the semiconductor region in the inverse mode is set to be large enough for the body diode to remain de-energized.
Patent FI-962300-A (FI)
Inventor: HAGEDORN OLAF
IPC: B65D27/00
Filed: 1996-05-31
Abstract: The invention relates to envelopes (3) made from waste paper. To this end, the recycled envelopes (3) are folded from pieces of waste paper obtained directly from paper waste so that its preparation does not require the use of any chemical additives, e.g. bleaches, and the addition of water. According to the invention, the waste paper collected and sorted for this purpose is cut into the sections (1) to be processed further, whereby the section shapes (1) and the position of the fold lines (2, 4, 6, 8) are advantageously laid out according to the waste paper sizes used. As the waste paper requires no laborious processing, the production and use of the envelopes (3) of the invention for postal and other purposes results in a particularly favourable eco-balance.
Patent FI-964815-A (FI)
Inventor: BRIGHTWELL CHRISTOPHER IAN
IPC: C07D401/12
Filed: 1996-12-02
Abstract: Compounds are disclosed which have the general formula A:    <IMAGE>  (A)  where Ra and Rb are each hydrogen or methyl and Rc is hydrogen, halo or C1-4 alkyl optionally in the form of a pharmaceutically acceptable acid addition salt. The compounds are useful in the treatment of CNS disorders.
Patent FI-982298-A (FI)
Inventor: LAGERBLOM NIKLAS
IPC: H03F1/32
Filed: 1998-10-23
Abstract: A method and arrangement for correcting a phase error in a linearization loop of a power amplifier, the loop comprising an I/Q modulator (10), one or more delay-causing power amplifiers (13) to be linearized, an I/Q demodulator (11) for generating I and Q feedback signals from the output signals of the amplifier (13), difference means (20, 21) of the I and Q branches for generating I and Q difference signals from the I and Q feedback signals and the I and Q input signals, the I/Q modulator and the I/Q demodulator receiving an oscillator frequency from the same local oscillator (14), and a phase shifter (17), the method comprising determination of a phase error resulting from the delay produced in the linearization loop, which determination comprises feeding excitation signals to the I and Q inputs (I IN, Q_IN) of the linearization loop, measuring the signals resulting from the excitation signals and calculating a phase error by means of the measured signals and excitation signals, and correcting the phase error by adjusting a phase of a local oscillator signal passing to the I/Q modulator or I/Q demodulator by means of a phase shifter (17), whereby on determining the phase error the signals resulting from the excitation signals are measured from the I and Q difference signals or the I and Q input signals of the I/Q modulator (10) and the phase determination is performed while the linearization loop is closed.
Patent GB-958799-A (GB)
Title: Electromagnetic wave transmission systems
IPC: H01Q19/19
Filed: 1961-01-11
Abstract: 958,799. Directive radio systems. T. HAFNER. Jan. 11, 1961 [Jan. 15, 1960], No. 1173/61. Heading H4A. In a radio beam transmission system, variations along the transmission path of the amplitude and phase distribution across a crosssection of the beam due to divergence or convergence of the beam are compensated by the provision of passive reflector units spaced along the transmission path. When the beam 4, Fig. 1, is divergent each reflector unit comprises a convex reflector 8 at the focus of a larger concave reflector 7 having a central aperture or wave transparent metal grid portion, Figs. 2 and 3 (not shown), through which the beam emerges after double reflection at 7 and 8. Additional correction may be effected by a wave transmission device, e.g. lens, in the central aperture of the reflector 7 or elsewhere. For a converging beam each pair of reflectors is arranged as shown in Fig. 4. The direction of the transmission path may be changed at a reflector unit by adjusting the direction of its axis. The beam may be generated and received by an aerial comprising a horn 1, Fig. 1, and a central conductor or dielectric rod 2. Specification 923,202 is referred to.